Insider Trading & Ownership - Seidel-Dugan Cynthia

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Seidel-Dugan Cynthia

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-02
Option Award
2024-01-04
4:30 pm
N/A
2033-12-31
Werewolf Therapeutics Inc.HOWLSeidel-Dugan Cynthia
Chief Scientific Officer
150,000$0150,000
(Direct)
View
2023-01-03
Option Award
2023-01-09
9:36 pm
N/A
2032-12-31
Werewolf Therapeutics Inc.HOWLSeidel-Dugan Cynthia
Chief Scientific Officer
115,900$0115,900
(Direct)
View
2022-01-12
Exercise
2022-01-14
5:58 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLSeidel-Dugan Cynthia
Chief Scientific Officer
24,199$1.56364,972
(Direct)
View
2022-01-12
Exercise
2022-01-14
5:58 pm
N/A
2030-05-19
Werewolf Therapeutics Inc.HOWLSeidel-Dugan Cynthia
Chief Scientific Officer
39,731$0364,972
(Direct)
View
2022-01-06
Option Award
2022-01-14
5:58 pm
N/A
2032-01-05
Werewolf Therapeutics Inc.HOWLSeidel-Dugan Cynthia
Chief Scientific Officer
79,516$0364,972
(Direct)
View
2022-01-12
Exercise
2022-01-14
5:58 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLSeidel-Dugan Cynthia
Chief Scientific Officer
15,532$4.77364,972
(Direct)
View
2020-12-08
Option Award
2021-05-04
4:31 pm
N/A
2030-12-07
Werewolf Therapeutics Inc.HOWLSeidel-Dugan Cynthia
Chief Scientific Officer
157,071$0157,071
(Direct)
View

Ownership
2021-04-29
4:57 pm
N/A
N/A
Werewolf Therapeutics Inc.HOWLSeidel-Dugan Cynthia
Chief Scientific Officer
0$0285,456
(Direct)
View